Vixiar Medical
Non-invasive devices and systems for monitoring cardiopulmonary diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
$1.5m | Series A | ||
| Total Funding | 000k | ||
Related Content
Vixiar Medical specializes in developing non-invasive devices and systems for monitoring cardiopulmonary diseases, particularly those with significant clinical and economic burdens. The company operates in the healthcare technology market, focusing on providing cost-effective and efficient solutions for heart failure monitoring. Vixiar's primary product is a handheld device designed to detect changes in intrathoracic fluid volume at the point of care, which can be used in various settings such as homes, offices, nursing homes, and hospitals. This device offers an alternative to more labor-intensive, expensive, or invasive approaches currently available.
The business model of Vixiar Medical involves the development and eventual commercialization of these medical devices, targeting healthcare providers, patients, and institutions that require reliable and non-invasive monitoring solutions. Revenue is generated through the sale of these devices and potentially through service agreements for ongoing monitoring and data analysis.
Vixiar Medical's innovative approach aims to improve patient outcomes while reducing healthcare costs, making it a valuable player in the medical technology industry.
Keywords: cardiopulmonary, non-invasive, heart failure, monitoring, handheld device, intrathoracic fluid, point of care, healthcare technology, cost-effective, clinical burden.